Urology Doctors in Fayetteville, AR Accepting Medicare

9 Urology doctors found. Showing 1 - 9

Richard D Mcwhorter, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2 East Appleby Rd., Suite 201, Fayetteville, AR 72703 Phone: 479-404-1100    Fax: 479-404-1101

William Vernon Fairchild, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301

Dr. Aleksandar Cody Blubaum, MD Urology Medicare: Medicare Enrolled Practice Location: 3 E Appleby Rd Ste 201, Fayetteville, AR 72703 Phone: 479-404-1100

Charles Mark Jackson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3 E Appleby Rd Ste 201, Fayetteville, AR 72703 Phone: 479-404-1100    Fax: 479-404-1101

Dr. Issam Toufic Shalhoub, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301

Michael R Wilson, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1300 E Zion Rd, Fayetteville, AR 72703 Phone: 479-521-8980    Fax: 479-521-8982

Truman Stephen Shaddox, M.D. Urology Medicare: Medicare Enrolled Practice Location: 12 E Appleby Rd, Ste 101, Fayetteville, AR 72703 Phone: 479-463-4444    Fax: 479-463-4499

Nirmal K Kilambi, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1300 E Zion Rd, Fayetteville, AR 72703 Phone: 479-521-8980    Fax: 479-521-1088

William E. Higginbothom Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1300 E Zion Rd, Fayetteville, AR 72703 Phone: 479-521-8980    Fax: 479-521-8982

News Archive

Study suggests novel approach for protecting diabetes patients from vascular disease

Recent findings suggest a novel approach for protecting people with diabetes from their higher risk of advanced blood vessel disease, which sets the stage for early heart attacks and strokes.

NIH awards two new grants to develop Avidocin platform

AvidBiotics today announced the receipt of two new grants totaling $1 million dollars from the National Institutes of Health that further the development of the company's novel Avidocin™ platform for narrow spectrum antibacterial proteins against important health care threats. These grants add to three previous grants covering AvidBiotics' anti-infectious disease technologies, which provide approximately $3.4 million in currently active funding for the company.

Sientra's breast implant approved by the U.S. FDA

The implant, manufactured by Santa Barbara-based Sientra, can be used for breast tissue reconstruction for women of any age and for breast augmentation in women 22 or older. The approval resulted from three years of clinical studies on almost 1,800 patients. Tightening of the area around the implant, re-operation, implant removal, uneven appearance and infection were some of the complications experienced during the study. Sientra is required to continue studies on the implant's long-term safety, effectiveness and risks of rare diseases under the approval.

Cardiac arrest represents tremendous problem for hospitals in the U.S.

More than 200,000 people are treated for cardiac arrest in United States hospitals each year, a rate that may be on the rise. The findings are reported online this week in Critical Care Medicine in a University of Pennsylvania Perelman School of Medicine-led study.

Read more Medical News

› Verified 5 days ago